According to the Centers for Disease Control and Prevention (CDC), more than 700,000
women have been diagnosed with cancer in the last five years. Cancers of the breast …

Abstract 1007 Background. The present study explores the in-vitro & in-vivo efficacy of
combining a new, non-toxic, cancer treatment modality, termed Tumor Treating Fields …

Bioelectronic medicine has tremendous potential in biomedical sector including oncology
research, research on biomechanical and chemical properties of cells and biomaterials …

Abstract Background Tumor Treating Fields (TTFields) therapy, an approved modality for the
treatment of glioblastoma, is currently being investigated in many other indications. These …

Background Malignant brain tumors are among the most threatening diseases of the central
nervous system, and despite increasingly updated treatments, the prognosis has not been …

Introduction As a novel treatment modality, tumor treating fields (TTFields) exert low-
intensity, medium-frequency electric fields on tumor cells. TTFields' effectiveness and safety …

Tumor treating fields (TTFields) are among clinically active anticancer modalities that utilize
low‐intensity, intermediate frequency (IF), and alternating electric fields (AEFs) to selectively …

Introduction: Local control is fundamental, both for the curative as well as the palliative
treatment of cancer. Tumor treating fields (TTFields) are low intensity (1–2 V/cm) …

Despite extraordinary advances that have been achieved in the last few decades, cancer
continues to represent a leading cause of mortality worldwide. Lethal cancer types ultimately …

Abstract Tumor Treating Fields (TTFields) are low intensity intermediate frequency
alternating electric fields that disrupt mitosis. Our previous in vitro studies suggest that …